Benjamin Epstein, PharmDCo-Founder/Board Member
Dr Epstein was trained at the University of Florida (UF) in Gainesville, Florida, where he obtained his Doctorate in Pharmacy and completed a residency and post-doctoral fellowship. Subsequently, he was invited to join the faculty at UF, where he accepted a joint appointment in the Colleges of Pharmacy and Medicine. While at UF, Dr Epstein developed and directed a successful research and teaching program. He has lectured nationally and internationally on various topics and has authored numerous articles published in New England Journal of Medicine, Drugs, American Family Physician, Current Opinion on Investigational Drugs, Pharmacotherapy, and Annals of Pharmacotherapy. During his tenure at UF, Dr Epstein was recruited by pharmaceutical, medical device and diagnostic companies as consultant, advisor, steering committee participant and speaker. It was in this capacity that Dr Epstein’s medical communications interests were cultivated. He envisioned a new generation of medical communications, with a focus on science and a novel client-vendor-consultant relationship. Dr Epstein founded ECIR in 2010 and has been instrumental in the Agency’s growth while also leading up the Scientific Affairs Division. Dr Epstein’s expertise resides in the areas of allergy, otolaryngology, cardiovascular disease, anticoagulation, endocrinology, pulmonology, rheumatology, gastroenterology, and drug interactions.